FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy

Ian G. Cannell(Cancer Research UK), Gregory J. Hannon(Howard Hughes Medical Institute)
Cell Reports
July 26, 2023
Cited by 52


Related Papers